Bill
Bill > HB1652
summary
Introduced
06/24/2025
06/24/2025
In Committee
06/24/2025
06/24/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of September 9, 1965 (P.L.497, No.251), entitled "An act requiring physicians, hospitals and other institutions to administer or cause to be administered tests for genetic diseases upon infants in certain cases," further providing for Newborn Child Screening and Follow-up Program.
AI Summary
This bill amends the Newborn Child Testing Act to add Gaucher disease to the list of conditions that must be screened for in newborn children. Gaucher disease is a rare genetic disorder that affects the body's ability to break down certain fatty substances, potentially leading to serious health complications. The bill requires the Pennsylvania Department of Health, with approval from the Newborn Screening and Follow-up Technical Advisory Board, to include Gaucher disease screening as part of its existing newborn screening program. The goal of this screening is to help healthcare providers identify potential health risks early and determine if treatment or other services are necessary to prevent intellectual disability, physical disability, or death. The bill will go into effect 60 days after its enactment, which will give healthcare providers and laboratories time to prepare to implement the new screening requirement.
Committee Categories
Health and Social Services
Sponsors (20)
Abigail Salisbury (D)*,
Lisa Borowski (D),
Joe Ciresi (D),
Tina Davis (D),
Justin Fleming (D),
Dan Frankel (D),
Liz Hanbidge (D),
Carol Hill-Evans (D),
Carol Kazeem (D),
Tarik Khan (D),
La'Tasha Mayes (D),
Jeanne McNeill (D),
Dan Miller (D),
Danielle Otten (D),
Chris Pielli (D),
Nikki Rivera (D),
Ben Sanchez (D),
Mike Schlossberg (D),
Jared Solomon (D),
Ben Waxman (D),
Last Action
Laid on the table (on 11/18/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...